In our subgroups analyses, patients with HCV-related HCC had inferior OS compared with patients with HBV-related HCC among patients with BCLC stages 0–A (p<0.001), AFP < 20 ng/ml (p = 0.03), and curative treatments (p = 0.019). Here, AFP is linked to hepatocellular carcinoma.